Jump to main content
Jump to site search

Issue 37, 2016
Previous Article Next Article

Ethionamide biomimetic activation and an unprecedented mechanism for its conversion into active and non-active metabolites

Author affiliations

Abstract

Ethionamide (ETH), a second-line anti-tubercular drug that is regaining a lot of interest due to the increasing cases of drug-resistant tuberculosis, is a pro-drug that requires an enzymatic activation step to become active and to exert its therapeutic effect. The enzyme responsible for ETH bioactivation in Mycobacterium tuberculosis is a monooxygenase (EthA) that uses flavin adenine dinucleotide (FAD) as a cofactor and is NADPH- and O2-dependant to exert its catalytic activity. In this work, we investigated the activation of ETH by various oxygen-donor oxidants and the first biomimetic ETH activation methods were developed (KHSO5, H2O2, and m-CPBA). These simple oxidative systems, in the presence of ETH and NAD+, allowed the production of short-lived radical species and the first non-enzymatic formation of active and non-active ETH metabolites. The intermediates and the final compounds of the activation pathway were well characterized. Based on these results, we postulated a consistent mechanism for ETH activation, not involving sulfinic acid as a precursor of the iminoyl radical, as proposed so far, but putting forward a novel reactivity for the S-oxide ethionamide intermediate. We proposed that ETH is first oxidized into S-oxide ethionamide, which then behaves as a “ketene-like” compound via a formal [2 + 2] cycloaddition reaction with peroxide to give a dioxetane intermediate. This unstable 4-membered intermediate in equilibrium with its open tautomeric form decomposes through different pathways, which would explain the formation of the iminoyl radical and also that of different metabolites observed for ETH oxidation, including the ETH–NAD active adduct. The elucidation of this unprecedented ETH activation mechanism was supported by the application of isotopic labelling experiments.

Graphical abstract: Ethionamide biomimetic activation and an unprecedented mechanism for its conversion into active and non-active metabolites

Back to tab navigation

Supplementary files

Publication details

The article was received on 21 Jul 2016, accepted on 23 Aug 2016 and first published on 25 Aug 2016


Article type: Paper
DOI: 10.1039/C6OB01561A
Citation: Org. Biomol. Chem., 2016,14, 8848-8858
  •   Request permissions

    Ethionamide biomimetic activation and an unprecedented mechanism for its conversion into active and non-active metabolites

    J. Laborde, C. Deraeve, C. Duhayon, G. Pratviel and V. Bernardes-Génisson, Org. Biomol. Chem., 2016, 14, 8848
    DOI: 10.1039/C6OB01561A

Search articles by author

Spotlight

Advertisements